| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/22/2001 | WO2001019784A1 Methods of preparing substituted tetracyclines with transition metal-based chemistries |
| 03/22/2001 | WO2001019397A1 Methods and compositions utilizing rad51 |
| 03/22/2001 | WO2001019395A1 Acellular immunogenic compositions and acellular vaccine compositions against bacillus anthracis |
| 03/22/2001 | WO2001019391A1 Topical treatment of streptococcal infections |
| 03/22/2001 | WO2001019385A2 The use of bacterial phage associated lysing enzymes for the prophylactic and therapeutic treatment of various illnesses |
| 03/22/2001 | WO2001019382A1 Pharmaceutical composition that contains eucalyptus and orange oil |
| 03/22/2001 | WO2001019366A1 Topical treatment for prevention of ocular infections |
| 03/22/2001 | WO2001019341A1 Method for modulating the metabolism of nitrogen oxides, compositions therefor (and variants) and method for acting on a patient's organism necessitating the metabolism of nitrogen oxides to be corrected |
| 03/22/2001 | WO2001019335A2 Composition to be administered through mucous membrane |
| 03/22/2001 | WO2001019322A2 Use of csaids in rhinovirus infection |
| 03/22/2001 | WO2001009332A3 Immunogenic polypeptides derived from moraxella catarrhalis and uses thereof |
| 03/22/2001 | WO2001000188A3 Tetrahydroquinolinyl-6-methyldihydrothiadiazinone derivatives and their use for preventing and/or treating anaemia |
| 03/22/2001 | WO2000074629A3 Composition for implementing a cytotoxic, in particular an antitumoral or antiviral, treatment in a mammal |
| 03/22/2001 | WO2000073323A3 Adam polynucleotides and polypeptides |
| 03/22/2001 | WO2000071693A3 Method for selecting improved vectors |
| 03/22/2001 | WO2000069862A3 Hemisynthetic method and intermediates thereof |
| 03/22/2001 | WO2000069255A8 Anti-inflammatory therapy for inflammatory mediated infection |
| 03/22/2001 | WO2000063240A9 ANTIFUNGAL AGENTS ISOLATED FROM $i(PSEUDOMONAS SYRINGAE) |
| 03/22/2001 | WO2000061134A8 Antimicrobial agents |
| 03/22/2001 | WO2000060066A8 Protein-protein from s. cerevisiae and methods of using same |
| 03/22/2001 | WO2000059899A8 Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them |
| 03/22/2001 | WO2000052037A8 Echinocandin/carbohydrate complexes |
| 03/22/2001 | WO2000045840A8 Compositions and methods for treating and preventing pathogenic bacterial infection based on the essential role of dna methylation in bacterial virulence |
| 03/22/2001 | WO2000040612A9 Insulin-like growth factor (igf) i mutant variants |
| 03/22/2001 | WO2000040576A3 Thiopyran compounds as inhibitors of mmp |
| 03/22/2001 | WO2000032177A3 Use of 17-ketosteroids in the treatment of hepatitis c virus and other togavirus infections |
| 03/22/2001 | WO1999058678A9 Antibodies to dendritic cells and human dendritic cell populations and uses thereof |
| 03/22/2001 | CA2672722A1 Methods of preparing substituted tetracyclines with transition metal-based chemistries |
| 03/22/2001 | CA2393896A1 Pteridinones as kinase inhibitors |
| 03/22/2001 | CA2386530A1 Viral replicons and viruses dependent on inducing agents |
| 03/22/2001 | CA2386525A1 Method for modulating the metabolism of nitrogen oxides, compositions therefor (and variants) and method for acting on a patient's organism necessitating the metabolism of nitrogen oxides to be corrected |
| 03/22/2001 | CA2385769A1 Kinase inhibitors as therapeutic agents |
| 03/22/2001 | CA2385747A1 Pyrazolopyrimidines as therapeutic agents |
| 03/22/2001 | CA2385722A1 Use of csaids in rhinovirus infection |
| 03/22/2001 | CA2385234A1 Nrage nucleic acids and polypeptides and uses thereof |
| 03/22/2001 | CA2384898A1 Antiviral agents |
| 03/22/2001 | CA2384881A1 The use of bacterial phage associated lysing enzymes for the prophylactic and therapeutic treatment of various illnesses |
| 03/22/2001 | CA2384876A1 Composition to be administered through mucous membrane |
| 03/22/2001 | CA2384860A1 Recombinant eggs and gene cloning and expression vectors based on avian adenoviruses |
| 03/22/2001 | CA2384783A1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 03/22/2001 | CA2384782A1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 03/22/2001 | CA2384733A1 Methods and compositions utilizing rad51 |
| 03/22/2001 | CA2384294A1 Nicotinic acetylcholine receptor: alpha10 subunit |
| 03/22/2001 | CA2384192A1 Pharmaceutical composition that contains eucalyptus and orange oil |
| 03/22/2001 | CA2384135A1 Dipeptidyl peptidases |
| 03/22/2001 | CA2384081A1 Recombinant microorganisms expressing an oligosaccharide receptor mimic |
| 03/22/2001 | CA2383177A1 Human g-protein coupled receptor |
| 03/22/2001 | CA2383038A1 Topical treatment of streptococcal infections |
| 03/22/2001 | CA2383003A1 Single stranded oligonucleotides, probes, primers and method for detecting spirochetes |
| 03/22/2001 | CA2382544A1 Methods of peptide preparation |
| 03/22/2001 | CA2382067A1 Recombinant microorganisms |
| 03/22/2001 | CA2382063A1 Charge-modified nucleic acid terminators |
| 03/21/2001 | EP1084709A1 Oral recombinant lactobacilli vaccines |
| 03/21/2001 | EP1084261A1 Recombinant venezuelan equine encephalitis virus vaccine |
| 03/21/2001 | EP1084252A1 Nucleic acid vaccines for prevention of flavivirus infection |
| 03/21/2001 | EP1084251A2 Attenuated pestiviruses |
| 03/21/2001 | EP1084246A2 Biological material for preparing pharmaceutical compositions for treating mammals |
| 03/21/2001 | EP1084147A1 Process for producing immunoglobulins for intravenous administration and other immunoglobulin products |
| 03/21/2001 | EP1084137A1 Peptide inhibitors of hepatitis c virus ns3 protease |
| 03/21/2001 | EP1084124A1 Benzothiazolythiomethyl carbapenem antibacterial |
| 03/21/2001 | EP1084110A1 Quinolones used as mrs inhibitors and bactericides |
| 03/21/2001 | EP1084105A1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
| 03/21/2001 | EP1084104A1 Nitric oxide synthase inhibitors |
| 03/21/2001 | EP1083932A1 Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine |
| 03/21/2001 | EP1083922A2 Composition and method for treatment of pseudomonas |
| 03/21/2001 | EP1083920A1 Novel antibacterial compounds |
| 03/21/2001 | EP1083919A1 Novel antiviral compounds |
| 03/21/2001 | EP1083916A1 IL-6/sIL-6R COMPLEX FOR PROMOTION OF LIVER FUNCTIONS |
| 03/21/2001 | EP1083909A1 hCEPR RECEPTOR |
| 03/21/2001 | EP1083908A1 Use of ozone for the preparation of medicaments for the treatment of dental caries |
| 03/21/2001 | EP1083901A1 Efavirenz compressed tablet formulation |
| 03/21/2001 | EP1083900A2 Topical administration of oxazolidinones for transdermal delivery |
| 03/21/2001 | EP1083898A1 Novel use of hiv protease inhibiting compounds |
| 03/21/2001 | EP1083886A1 Drug delivery system comprising a tightly compacted solid medicament stock |
| 03/21/2001 | EP1083883A1 Stabilizers for lyophilized vaccines |
| 03/21/2001 | EP1083881A2 Liposome composition and method for administering a quinolone |
| 03/21/2001 | EP1083856A1 Topical transdermal treatments |
| 03/21/2001 | EP0938310A4 Anti-viral compounds |
| 03/21/2001 | EP0833662B1 A vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate |
| 03/21/2001 | EP0734529B1 Methods and materials for the detection of staphylococcus aureus |
| 03/21/2001 | CN1288462A Oxazolidinone combinatorial libraries, compositions and method of prepn. |
| 03/21/2001 | CN1288384A Lipooligosaccharide-based vaccine for prevention of i(moraxella) i(branhamella) i (catarrhalis) infections in mammals |
| 03/21/2001 | CN1288378A Celecoxib compositions |
| 03/21/2001 | CN1288370A Mixture contg. honey, at least one essential oil and/or at least one essential oil derivative |
| 03/21/2001 | CN1287856A Compound medicinal powder for treating tuberculosis |
| 03/21/2001 | CN1287847A Medicine for preventing and treating disease of ell |
| 03/21/2001 | CN1287842A Belt like plaster |
| 03/21/2001 | CN1287840A Medicine for treating gynecological chronic inflammation and its prepn. method |
| 03/21/2001 | CN1063322C Aqueous liquid composition for eye external use as eyedrops |
| 03/21/2001 | CN1063320C Bathing preparation for pets against diseases and method for preparation of same |
| 03/20/2001 | US6204415 2,2-difluoro-2-ethylthioacetophenone derivatives of given formula which have use as intermediates to antimycotic agents |
| 03/20/2001 | US6204371 Compositions and methods for the treatment and diagnosis of immune disorders |
| 03/20/2001 | US6204295 Halogenated triphenylethylene derivatives,protection of human organs, from oxidative damage induced by lipid peroxidation and inhibiting the production of reactive oxygen species by activated neutrophils |
| 03/20/2001 | US6204276 Dicarboxylic germanium complex and its therapeutic use |
| 03/20/2001 | US6204262 1,3-Benzodiazepin-2-ones and 1,3-Benzoxazepin-2-ones useful as HIV reverse transcriptase inhibitors |
| 03/20/2001 | US6204261 Inhibitors of interleukin-1β Converting enzyme inhibitors |
| 03/20/2001 | US6204250 Immunization of infants |
| 03/20/2001 | US6204249 For the treatment or prophylaxis of virus infections such as those caused by herpes viruses. |
| 03/20/2001 | US6204248 Pharmaceutical preparations of glutathione and methods of administration thereof |
| 03/20/2001 | US6204045 Genetically engineered infectious laryngotracheitis virus; for the development of vaccines against viral disease |